Mrs Sharon Hodgson

Mrs Sharon Hodgson

Labour — Washington and Gateshead South

Speaking in the House of Commons on 17 November 2026

Debate

Medicines and Healthcare Products Regulatory Agency

Contribution

I agree that there are lessons to be learned from across the world. If one country is looking at the harm that some drug or medical device is causing to patients, then the rest of the world should take notice, but there are so many examples where that just does not happen. In 2018, the MHRA confirmed three deaths associated with mesh incontinence procedures. That is the very same MHRA that in its “Strategy 2030” described itself as having an “overriding priority of patient safety.” As recently as last night, at a reception on the Terrace in Parliament, I listened to speeches by the senior people at the MHRA and had conversations with people working there about how patient safety is at the centre of everything that they do. That might indeed be the MHRA’s genuine ambition now, but we cannot forget the failures of the very recent past: there are women and children today living with the consequences of its failures. Where was patient safety as recently as 2017, when it deemed that mesh was safe for use in surgery despite its harms already being public knowledge? It seems to me, and maybe to all of us here today, that patient safety is not always the overriding priority that it should be for the MHRA. Patient safety also seems to be forgotten when it comes to financial conflicts of interest. During the covid-19 vaccine roll-out, several experts on the advisory committee had undisclosed financial ties to the vaccine companies. There are current reports of hernia mesh surgeons receiving undisclosed financial donations from mesh suppliers. Even since the complications of using plastic mesh were brought to light, it has often been reported that there is a revolving door between those working for the MHRA—the independent regulator—and those working in the industry. What guardrails are in place, such as there are for Government, Ministers and Parliament, to ensure that transparency and patient safety are paramount? MPs have to disclose everything that might give rise to a conflict of interest, but in the medical profession, with medical devices and drugs, that is not the case. In my opinion that is wrong. I heard last night that the MHRA is launching a new programme to tackle gaps in women’s health—something that I and, I am sure, many of us here today would welcome. However, in the past, the MHRA has failed women, with little remedy and, as far as I am aware, not even an apology. As we heard from the right hon. Member for Tatton, the yellow card reporting system has been known to capture only a fraction of medicinal side effects and medical device complications. After the Cumberlege review, the medical devices outcomes registry was set up in 2024 as an avenue for medical device performance to be reviewed by healthcare professionals, with the intention of linking the registry to the MHRA’s current data. Two years later, MDOR still has not been associated with the MHRA’s yellow card system, leaving medical devices unbeknown to the scrutiny of the regulator. If the MHRA is failing its audits on existing treatment outcomes, how will the women of tomorrow be reassured by the investment in women’s health that it launched yesterday? We promised victims of thalidomide decades ago that this would never happen again; we told victims of sodium valproate that we were very sorry that their children had been put through what they were put through; just three weeks ago at Prime Minister’s questions, the Prime Minister said from the Dispatch Box that he would ensure that there is justice for the victims of Primodos—another scandal that Baroness Cumberlege covered in her report—on his watch; and we assured the victims of mesh that they would be listened to and put first in conversations about patient safety. So why does this keep happening? What drug or medicinal device are we prescribing now that has been rushed through regulations without proper checks? When will enough be enough, and when will the MHRA finally be held accountable for its part in these scandals?

More from Mrs Sharon Hodgson

Other recent Hansard contributions by the same speaker.

About Hansard

Hansard is the official verbatim record of proceedings in the UK Parliament. Every word spoken in the Commons and Lords is recorded and published — this page is a single contribution from that record.

For Mrs Sharon Hodgson's full parliamentary record including voting history, expenses and all other contributions, see the Mrs Sharon Hodgson report card.